343 related articles for article (PubMed ID: 12644349)
1. "Routine invasive" versus "selective invasive" approaches to non-ST-segment elevation acute coronary syndromes management in the post-stent/platelet inhibition era.
Boden WE
J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):113S-122S. PubMed ID: 12644349
[TBL] [Abstract][Full Text] [Related]
2. Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) Trials.
Damman P; van Geloven N; Wallentin L; Lagerqvist B; Fox KA; Clayton T; Pocock SJ; Hirsch A; Windhausen F; Tijssen JG; de Winter RJ
JACC Cardiovasc Interv; 2012 Feb; 5(2):191-9. PubMed ID: 22361604
[TBL] [Abstract][Full Text] [Related]
3. Use of coronary revascularization in patients with unstable and non-ST-segment elevation acute myocardial infarction.
Popma JJ; Suk J
Am J Cardiol; 2001 Oct; 88(8A):25K-29K. PubMed ID: 11694216
[TBL] [Abstract][Full Text] [Related]
4. Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy. Thrombolysis In Myocardial Infarction.
Cannon CP; Weintraub WS; Demopoulos LA; Robertson DH; Gormley GJ; Braunwald E
Am J Cardiol; 1998 Sep; 82(6):731-6. PubMed ID: 9761082
[TBL] [Abstract][Full Text] [Related]
5. An ischemia-guided approach for risk stratification in patients with acute coronary syndromes.
Pepine CJ
Am J Cardiol; 2000 Dec; 86(12B):27M-35M. PubMed ID: 11206016
[TBL] [Abstract][Full Text] [Related]
6. Interpreting new treatment guidelines for non-ST-segment elevation acute coronary syndromes.
Boden WE
Am J Cardiol; 2001 Oct; 88(8A):19K-24K. PubMed ID: 11694215
[TBL] [Abstract][Full Text] [Related]
7. Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era.
Fanning JP; Nyong J; Scott IA; Aroney CN; Walters DL
Cochrane Database Syst Rev; 2016 May; 2016(5):CD004815. PubMed ID: 27226069
[TBL] [Abstract][Full Text] [Related]
8. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
[TBL] [Abstract][Full Text] [Related]
9. Early invasive versus conservative strategies for unstable angina and non-ST elevation myocardial infarction in the stent era.
Hoenig MR; Aroney CN; Scott IA
Cochrane Database Syst Rev; 2010 Mar; (3):CD004815. PubMed ID: 20238333
[TBL] [Abstract][Full Text] [Related]
10. "Ischemia-guided" versus "early invasive" strategies in the management of acute coronary syndrome/non-ST-segment elevation myocardial infarction: the interventionalist's perspective.
McKay RG
J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):96S-102S. PubMed ID: 12644347
[TBL] [Abstract][Full Text] [Related]
11. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
Cannon CP; Weintraub WS; Demopoulos LA; Vicari R; Frey MJ; Lakkis N; Neumann FJ; Robertson DH; DeLucca PT; DiBattiste PM; Gibson CM; Braunwald E;
N Engl J Med; 2001 Jun; 344(25):1879-87. PubMed ID: 11419424
[TBL] [Abstract][Full Text] [Related]
12. Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era.
Hoenig MR; Doust JA; Aroney CN; Scott IA
Cochrane Database Syst Rev; 2006 Jul; (3):CD004815. PubMed ID: 16856061
[TBL] [Abstract][Full Text] [Related]
13. Benefit of an early invasive management strategy in women with acute coronary syndromes.
Glaser R; Herrmann HC; Murphy SA; Demopoulos LA; DiBattiste PM; Cannon CP; Braunwald E
JAMA; 2002 Dec; 288(24):3124-9. PubMed ID: 12495392
[TBL] [Abstract][Full Text] [Related]
14. Small molecule glycoprotein IIb/IIIa receptor inhibitors as upstream therapy in acute coronary syndromes: insights from the TACTICS TIMI-18 trial.
Cannon CP
J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):43S-48S. PubMed ID: 12644340
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet intervention in acute coronary syndrome.
Arora RR; Rai F
Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
[TBL] [Abstract][Full Text] [Related]
16. Interpretation of new treatment guidelines for non-ST-segment elevation acute coronary syndromes: "ischemia-guided" versus "early invasive" strategies.
Boden WE
Minerva Cardioangiol; 2003 Oct; 51(5):447-61. PubMed ID: 14551515
[TBL] [Abstract][Full Text] [Related]
17. Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale.
Stone GW; Bertrand M; Colombo A; Dangas G; Farkouh ME; Feit F; Lansky AJ; Lincoff AM; Mehran R; Moses JW; Ohman M; White HD
Am Heart J; 2004 Nov; 148(5):764-75. PubMed ID: 15523305
[TBL] [Abstract][Full Text] [Related]
18. Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction.
Mahoney EM; Jurkovitz CT; Chu H; Becker ER; Culler S; Kosinski AS; Robertson DH; Alexander C; Nag S; Cook JR; Demopoulos LA; DiBattiste PM; Cannon CP; Weintraub WS;
JAMA; 2002 Oct; 288(15):1851-8. PubMed ID: 12377083
[TBL] [Abstract][Full Text] [Related]
19. Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature.
Bavry AA; Kumbhani DJ; Quiroz R; Ramchandani SR; Kenchaiah S; Antman EM
Am J Cardiol; 2004 Apr; 93(7):830-5. PubMed ID: 15050484
[TBL] [Abstract][Full Text] [Related]
20. The early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation acute coronary syndrome (EARLY ACS) trial: a randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non-ST-segment elevation acute coronary syndrome--study design and rationale.
Giugliano RP; Newby LK; Harrington RA; Gibson CM; Van de Werf F; Armstrong P; Montalescot G; Gilbert J; Strony JT; Califf RM; Braunwald E;
Am Heart J; 2005 Jun; 149(6):994-1002. PubMed ID: 15976780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
